Bio-Techne Announces Launch of Cultrex UltiMatrix BME to Support Organoid and Pluripotent Stem Cell Cultures

Rhea-AI Summary

Bio-Techne Corporation (NASDAQ: TECH) announces the launch of Cultrex™ UltiMatrix™ Reduced Growth Factor Basement Membrane Extract (RGF BME), an innovative extracellular matrix hydrogel aimed at enhancing organoid and pluripotent stem cell cultures. This product features increased total protein content, optimized protein composition, and improved tensile strength, while also reducing reliance on growth factors. Dave Eansor, President of Protein Sciences Segment, emphasizes its importance for drug discovery and regenerative medicine, addressing a critical market need.

Positive

• Launch of UltiMatrix RGF BME enhances capabilities in organoid and stem cell research.
• Product improvements include increased total protein content and optimized composition.
• Reduces dependency on supplemental growth factors, potentially lowering research costs.

Negative

• None.

MINNEAPOLIS, March 29, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced the release of Cultrex™ UltiMatrix™ Reduced Growth Factor Basement Membrane Extract (RGF BME), an extracellular matrix hydrogel that provides significant performance and consistency benefits for culturing organoids and pluripotent stem cells. UltiMatrix RGF BME addresses the market need for a dependable, high concentration cell scaffolding matrix with compositional and physical properties specifically designed for use in generating advanced 2D and 3D cell culture models. Cultrex UltiMatrix RGF BME matrix improvements include increased total protein content, optimized extracellular matrix protein composition, high levels of entactin, and improved tensile strength while reducing the dependency on supplemental growth factors.

"Cultrex UltiMatrix BME offers improvements to matrix hydrogels that are urgently needed to support the increased use of organoids and pluripotent stem cells for drug discovery research, personalized medicine, and regenerative medicine. We're very excited to add this advanced matrix to our portfolio," said Dave Eansor, President, Protein Sciences Segment.

The full line of Cultrex BME can be found on the R&D Systems Website: Cultrex BME

Bio-Techne continues to support organoid and stem cell research by manufacturing reagents critical for cell culture, including recombinant proteins, small molecules, extracellular matrices, media and media supplements.

About Bio-Techne Corporation (NASDAQ: TECH)

Contact: 
David Clair, Senior Director, Investor Relations and Corporate Development 
david.clair@bio-techne.com
612-656-4416 

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/bio-techne-announces-launch-of-cultrex-ultimatrix-bme-to-support-organoid-and-pluripotent-stem-cell-cultures-301254828.html

SOURCE Bio-Techne Corporation

FAQ

What is Cultrex™ UltiMatrix™ Reduced Growth Factor Basement Membrane Extract?

Cultrex UltiMatrix RGF BME is an extracellular matrix hydrogel designed for culturing organoids and pluripotent stem cells, offering various performance and consistency benefits.

When was the Cultrex UltiMatrix RGF BME launched?

Bio-Techne Corporation launched the Cultrex UltiMatrix RGF BME on March 29, 2021.

How does UltiMatrix RGF BME improve cell cultures?

It provides increased total protein content, an optimized protein composition, and enhanced tensile strength while reducing reliance on growth factors.

Which markets will benefit from Cultrex UltiMatrix RGF BME?

The product supports drug discovery research, personalized medicine, and regenerative medicine.